ABSTRACT Histone modifying enzymes play critical roles in cell differentiation and development. In this study, we report that SMYD2 (SET and MYND domain containing protein 2), a histone lysine methyltransferase, is induced during human embryonic stem (ES) cell differentiation and it is preferentially expressed in somatic cells versus pluripotent cells. Knockdown of SMYD2 in human ES cells promotes the induction of endodermal markers during differentiation, while overexpression has opposite effects. In vivo experiments in zebrafish revealed that knockdown of smyd2a (a homologue gene of human SMYD2) causes developmental delay and aberrant tail formation, which is coincident with low expression of ntl and over induction Nodal-related genes during gastrulation. Taken together, these findings suggest that SMYD2 plays a critical role at early stages of development and in human ES cell differentiation.
Introduction
Embryonic stem (ES) cells are characterized by their ability to self-renew indefinitely in vitro maintaining their undifferentiated state, and the capacity to give rise to any cell type in the body (Thomson et al., 1998) . The molecular mechanisms underlying ES cells identity and their potential for differentiation are still poorly understood (Boyer et al., 2005 , Niwa, 2007 . During the last years, post-translational covalent modifications of histone proteins have emerged as a crucial epigenetic event to regulate the pluripotent state of ES cells and to establish cell fate decisions (Bibikova et al., 2008 , Goldberg et al., 2007 , Meissner, 2010 . Histone modifications help to define chromatin structure and can be associated with active marks, offering accessible DNA for transcription, and repressive marks, where DNA is more packaged and inaccessible Lau, 2005, Kouzarides, 2007) . One particular property of ES cells is that many developmental genes present both active H3K4 and repressive H3K27 methylation on their regulatory regions, the so-called "bivalent domains" (Azuara et al., 2006 , Bernstein et al., 2006 . This bivalency keeps these genes silenced in ES cells, but "poised" to become activated by losing the repressive mark, or kept silenced by removal of active marks during differentiation (Spivakov and Fisher, 2007) .
In order to select candidates of histone modifying enzymes involved in pluripotency and differentiation of human ES cells, we identified a group of histone lysine demethylases and methyltransferases differentially expressed between undifferentiated and differentiated human ES cells (data not shown). Among them, SMYD2 emerged as a potential candidate due to its barely expression in undifferentiated human ES cells and later up-regulation after 30 days of differentiation towards the three germ layers. The SMYD (SET and MYND domain) protein family presents methyltransferase activity provided by its SET domain, which is split into two segments by its MYND domain, responsible for protein-protein interactions (Brown et al., 2006) . In human, there are five members in the SMYD protein family (SMYD1-5) and have been shown to participate regulating gene transcription and cell proliferation. SMYD1 is a heart and muscle specific histone methyltransferase involved in cardiomyocyte and myogenic differentiation (Gottlieb et al., 2002 , Li et al., 2009 . The lack of Smyd1 in mice development results in embryonic death due to cardiac defects (Gottlieb et al., 2002) . Knockdown of smyd1a/b in zebrafish causes skeletal and cardiac muscle defects and presents a disrupted expression of myofibril organization (Tan et al., 2006) , SMYD3 has been mainly human cancer showed high levels of SMYD2 expression (Cho et al., 2012 , Komatsu et al., 2009 . It was also reported that SMYD2 is involved in maintaining self-renewal activity of MLL-AF9-induced acute myeloid leukaemia (Zuber et al., 2011) . Another novel nonhistone substrate for SMYD2, cytoplasmic HSP90, is methylated at K209 and K615 (Abu-Farha et al., 2011) . In mouse, Smyd2 methylates HSP90 to form a complex with the sarcomeric protein titin to protect myocyte organization (Donlin et al., 2012 , Voelkel et al., 2012 . Here we reported the characterization of SMYD2 during human ES cell differentiation. Our data suggest that SMYD2 plays an important role during early differentiation events.
Results

SMYD2 expression is strongly induced during human ES cell differentiation
We first set up to analyze the potential differential expression of the SMYD family members in pluripotent and somatic cells by qPCR. mRNA levels of all five SMYD family members were measured in human embryonic stem (ES) cells (ES[2] and ES]4]), induced pluripotent (iPS) cells derived from human keratinocytes (KiPS) and human fibroblasts (HF) and keratinocytes (HEK) (Fig.  1A) . Among all family members, SMYD2 clearly showed higher mRNA levels in somatic cells compared to pluripotent cells. We next tested the expression profile of the SMYD family members during the differentiation of human ES cells in the form of embryoid bodies (Fig. 1B) . As expected, SMYD2 showed the most remark- related with cancer cell proliferation (Hamamoto et al., 2004) . Several findings indicate that endogenous expression of SMYD3 is present at very high levels in hepatocellular, colon and breast carcinoma, and silencing through siRNAs have an inhibitory effect in cell growth (Hamamoto et al., 2004 , Hamamoto et al., 2006 . Similarly to smyd1a/b, smyd3 plays an important role in cardiac and skeletal muscle development in zebrafish (Fujii et al., 2011) . In the other hand, SMYD4 is significantly reduced in tumor cells and its re-expression dramatically decreases cancer cell growth (Hu et al., 2009) . Also, Drosophila SMYD4 homologue has been involved in muscle development (Thompson and Travers, 2008) . Little is known so far about SMYD5. Unlike the rest of family members, SMYD5 does not present a C-terminal tetratrico peptide repeat (TPR) domain (Abu-Farha et al., 2011) .
SMYD2 was first described as a histone lysine methyltransferase mainly expressed in heart and brain tissue, with specific catalytic activity for H3K36 dimethylation, a mark associated with actively transcribed genes (Brown et al., 2006) . Moreover, SMYD2 was associated to interact with HDAC1 and the Sin3A repression complex (Brown et al., 2006) . In yeast, there is evidence of a link between H3K36 methylation and the recruitment of a repressive Rpd3 (the prototypical yeast HDAC) complex (Carrozza et al., 2005 , Joshi and Struhl, 2005 , Keogh et al., 2005 . However, SMYD2 was also described to specifically monomethylate H3K4 in the presence of HSP90a in vitro, with no activity for H3K36 (Abu-Farha et al., 2008) . Despite observing a weak activity of H3K36 methylation in the absence of HSP90a, in vivo experiments suggested that H3K4 is the predominant site of methylation for SMYD2 (Abu-Farha et al., 2008) . Regarding histone methylation, recent studies determined that SMYD2 also methylates histones H2B and H4 more efficiently than H3 in vitro (Wu et al., 2011) . Further, several non-histone proteins have been identified as substrates for SMYD2 methylation such as p53 and retinoblastoma (Rb) (Cho et al., 2012 , Huang et al., 2006 , Jiang et al., 2011 , Saddic et al., 2010 , Scoumanne and Chen, 2008 . Monomethylation of p53 at K370 reduces its binding ability to promoter target genes like p21 and mdm2, resulting in a decreased expression of these genes (Huang et al., 2006) . Unexpectedly, adult hearts of Smyd2 conditional knockout mice showed no changes in p21 and mdm2 expression levels, and had no global effect in H3K36 or H3K4 methylation (Diehl et al., 2010) . Additionally, Smyd2 was found dispensable for proper heart development in mouse (Diehl et al., 2010) . Rb protein can be methylated by SMYD2 at K860 and facilitates its interaction with the methyl-binding protein L3MBTL1 (Saddic et al., 2010) . More recently, SMYD2 was also found to methylate Rb at K810, which increases phosphorylation of Rb protein, and promotes cell cycle progression (Cho et al., 2012) . In accordance with the effects observed on p53 and Rb tumour suppressors, a wide variety of 
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able induction among the SMYD family members, which is coincident with the dowregulation of the expression of pluripotency-related genes (Fig. 1C ). Taken together, our results show that SMYD2 is preferentially expressed in human somatic cells and induced during the differentiation of human pluripotent cells.
SMYD2 promoter presents active chromatin marks in human ES cells
Since SMYD2 is expressed at low levels in human ES cells but rapidly induced during differentiation we considered the potential presence of bivalent domains on its promoter in pluripotent cells. We performed ChIP assay to detect the presence of histone marks related with transcriptional activation (H3K4me) and repression (H3K27me) in ES [4] and ES[2] (Fig. 2) . As a control, we tested the presence of histone marks for the pluripotency gene OCT4, and two well described genes containing bivalent domains in human ES were detected between the SMYD2 and GFP overexpressing cell lines regarding the silencing of pluripotency genes during differentiation. These results confirm that SMYD2 acts as a repressor of endodermal genes and has no effect in the downregulation of pluripotency genes during human ES differentiation.
The knockdown of smyd2a in zebrafish results in tail formation defects
To assess the effect of SMYD2 at early stages of development we performed knockdown experiments in zebrafish as in vivo model. The zebrafish presents two homologous genes of smyd2a and smyd2b. We first quantified the mRNA levels of both genes during zebrafish development from 0.2 to 48 hours post-fertilization (hpf) (Fig. 4A ). Interestingly, smyd2a was maternally expressed, rapidly degraded after fertilization and induced again during gastrulation (5 to 10 hpf). smyd2b expression levels remained low until 10 hpf and was dramatically induced after gastrulation. The induction of smyd2a during gastrulation suggests a potential role in germ layer specification. To confirm our hypothesis we designed a spliceblocking morpholino (smyd2a-MO) at the exon 1-intron 1 junction, to block proper splicing of the zygotic transcripts without affecting the maternal mRNA (Fig. 4B, upper panel) . Zebrafish embryos were injected at one-cell stage with smyd2a-MO and a standardcontrol morpholino (Control-MO). As expected, the mature mRNA of smyd2a was undetectable in embryos injected with smyd2a-MO at 24 hpf compared to embryos injected with Control-MO, while smyd2b expression was unaffected by the injection of smyd2a-MO (Fig. 4B, lower panel) . Injected embryos were examined morphologically up to 6 days after injection (Fig. 4C) . At 5 hpf, smyd2a-MO injected embryos could not be morphologically distinguished from the controls. At 24 hpf, we could detect some smyd2a morphant embryos with a tail defect (mild), and some others with a strong delay in development (severe). At 48 hpf, we could observe several degrees of tail defects, including a morphant phenotype with a complete absence of the tail (very severe). Later on, at 6 days after injection, all three smyd2a morphant phenotypes were distinguishable. To further confirm the specificity of smyd2a-MO effect, we performed a rescue experiment by co-injecting with in vitro-transcribed human SMYD2 mRNA (smyd2a-MO + SMYD2 mRNA) and evaluated the percentage embryos with different phenotypes at 24h post-injection (Fig. 4D) . 
The knockdown of SMYD2 promotes induction of endodermal genes during human ES cell differentiation
To test if SMYD2 is plays a role in the differentiation of human ES cells we performed loss-of-function experiments. We generated lentiviral-transduced stable ES[4] cell lines expressing a shRNA against SMYD2 (shSMYD2) (Huang et al., 2006) and a random non target shRNA (shControl). In self-renewing cells, the knockdown of SMYD2 did not show any morphological differences compared to the control, neither differences regarding the expression of selected pluripotency and differentiation genes (data not shown). However, during in vitro differentiation the SMYD2 knockdown line showed higher levels of endodermal genes (HNF4, FOXA2, SOX17) compared to the shControl line (Fig. 3A) , but not significant differences in the induction of ectordermal (PAX6) or mesodermal (BRACHYURY) genes. The pluripotency-related genes OCT4, NANOG and SOX2 were similarly downregulated in the shSMYD2 and shControl lines. Our results suggest that SMYD2 might act as a negative regulator of endodermal differentiation.
SMYD2 overexpression impairs proper differentiation of human ES cells
To further confirm the involvement of SMYD2 in differentiation we generated stable ES[4] cell lines stably overexpressing SMYD2 (SMYD2) or GFP as a control (GFP). The overexpression of SMYD2 in self-renewing cells did not cause significant morphological differences neither differences in the expression of selected pluripotency and differentiation genes compared to the control (Fig. 3B) . Contrary to the knockdown, cells overexpressing SMYD2 showed a reduced induction of endodermal and mesodermal genes compared to the control line during differentiation (Fig. 3B) . However, the ectodermal gene PAX6 was more induced in SMYD2 overexpressing cells than control cells. No differences co-injection of smyd2a-MO with human SMYD2 mRNA rescues both mortality (from 57% to 36%) and morphology (from 25% mild and 60% severe phenotype to 11% mild and 18% severe phenotype). Co-injection of human SMYD2 mRNA and Control-MO had no effects on mortality or phenotype compared to the injection of Control-MO alone. Therefore, the effects of smyd2a knockdown in zebrafish development appear specific. smyd2a knockdown in zebrafish affects the expression of genes involved in the Nodal pathway
To gain insights into the potential pathways affected by the smyd2a knockdown we investigated the expression pattern of the T-box gene no tail (ntl), a zebrafish Brachyury ortholog required for the formation of mesoderm and essential for tail development (Halpern et al., 1993 , Schulte-Merker et al., 1994 , by whole-mount in situ hybridization (ISH) on embryos at 6 hpf ( Fig. 5A) . As expected, all control embryos showed ntl expression at the margin cells as gastrulation proceeds. In contrast, most smyd2a-MO injected embryos showed altered pattern of ntl expression characterized by either a reduction (35% of embryos) or complete absence of ntl expression (53% of embryos). Moreover, the ratio of the three different ntl expression patters in smyd2a morphants is similar to the percentages of different phenotypes at 24 hpf (Fig. 4D , Table 1 ). To further identify specific transcripts affected by smyd2a knockdown, we analyzed the expression profile of a set of genes involved in gastrulation from 4 hpf to 10 hpf by qPCR (Fig. 5B) . Nodal-related genes (chd, gsc, bon and cas) were up-regulated in the smyd2a-MO compared to the Control-MO. In addition to their strong induction, gsc and bon presented also a different profile of expression as they were still present at high levels even at 8 hpf, while the control-MO injected embryos had already reduced their expression levels. bmp2a and b-catenin-1 are unaffected by smyd2a knockdown, suggesting that genes of the Bmp2 and Wnt pathways remain unaffected. These results indicate that smyd2a knockdown causes an induction of Nodal-target genes chd, gsc, bon and cas during gastrulation events in zebrafish.
Discussion
In this work we show that SMYD2 is involved in human ES cell differentiation. SMYD2 is expressed at high levels in somatic cells compared with pluripotent cells, whereas the rest of family members are not so differentially expressed. During human ES cell differentiation, SMYD2 is also the most induced family member. SMYD1 and 3, which share the highest degree of sequence homology with SMYD2 (Abu-Farha et al., 2011) , are also induced but not so remarkably. SMYD3 present a progressive induction but only around 3-fold change compared with undifferentiated cells. Even at low levels, SMYD1 was induced during differentiation reaching its peak of expression at day 8. This indicates that SMYD1 might be involved also in early development, consistent with previous studies involving Smyd1 in mouse developing heart as a direct target of MEF2C (Phan et al., 2005) . Given the low levels of expression of SMYD2 in pluripotent cells, we hypothesized the presence of bivalent domains on its promoter to keep it repressed. Unexpectedly, we found variable levels of H3K27me3 between cell lines. In ES[4] the SMYD2 promoter was marked with H3K4 methylation marks only, suggesting that SMYD2 expression could be blocked by an alternative mechanism. Recently, Lipchina et al., (Lipchina et al., 2011) identified SMYD2, together with other 145 genes, as a high-confidence target of the miR-302/367 cluster in human ES cells. miR-302/367 is expressed in undifferentiated conditions and is downregulated upon neuronal differentiation, releasing the expression of its target genes (Lipchina et al., 2011) . Thus, a possible miR-302/367 regulation of SMYD2 might explain the low levels of expression in pluripotent cells.
The knockdown of SMYD2 promoted the induction of endodermal genes during human ES cell differentiation, whereas overexpression had opposite effects. We further investigated the effect of SMYD2 depletion in vivo using the zebrafish as a model. Our results show that both smyd2a and smyd2b were induced during development, and surprisingly, smyd2a was found to be maternally expressed in zebrafish embryos. Knockdown of smyd2a causes a delay in zebrafish development and tail deformities in more than 80% of surviving embryos at 24 hpf, whereas rescue experiments reduced the morphant phenotype to 30%. The fact that we were able to rescue smyd2a morphant phenotype by co-injecting human SMYD2 mRNA suggests a very well conserved function of SMYD2 among species. Intriguingly, it was recently reported that smyd2a knockdown generates severe skeletal and cardiac muscle defects in zebrafish (Donlin et al., 2012 , Voelkel et al., 2012 . Regarding the cardiac phenotype, we did not appreciate any abnormalities, even in the very severe morphant phenotype at 6 dpf, consistent with mice conditional-knockout experiments where Smyd2 was dispensable for heart development (Diehl et al., 2010) .
The smyd2a knockdown phenotype that we observe is characteristic of embryonic dorsalization and resembles the phenotype of ntl mutant embryos (Odenthal et al., 1996) . Accordingly, the observed and Sin3a repression complexes (Brown et al., 2006) . However, methylation of non-histone targets might also account for these effects. For example, recent findings indicate that p53 knockdown causes a delay in differentiation of human ES cells, and ectopic expression of p53R175H, a mutated inactive form of p53, failed to induce differentiation (Jain et al., 2012) .
In summary, our study shows that SMYD2 is expressed at low levels in pluripotent cells but is strongly induced during differentiation. Knockdown of SMYD2 induced expression of endodermal genes, whereas overexpression leads to a blockade of differentiation by impairing induction of most of differentiation genes. Moreover, in vivo experiments in the zebrafish showed that smyd2a is involved in mesoderm formation and has a critical role from very early stages during development. In conclusion, our work suggests that SMYD2 plays an early decisive role in embryonic differentiation.
Materials and Methods
Cell culture and differentiation
Human embryonic stem cell lines ES[4] and ES[2] (Raya et al., 2008) , were grown on matrigel-coated plates in irradiated mouse embryonic fibroblasts conditioned HES media (Knock out DMEM, 20% Knock out serum replacement, nonessential amino acids, 2mM L-glutamine and 50mM b-mercaptoethanol) and supplemented with 10ng/ml FGF.
For in vitro differentiation, cells were trypsinized into a single cell suspension and resuspended in MEF-conditioned HES media. Embryoid body (EB) formation was induced by seeding 100,000 cells in each well of 96-well v-bottom, low attachment plates and centrifuging the plates at 950 g for 5 min to aggregate the cells. After 3 days the embryoid bodies were transferred to 0.1% gelatin-coated dishes and cultured in differentiation medium (Knock out DMEM, 20% fetal bovine serum, nonessential amino acids, 2mM L-glutamine and 50mM b-mercaptoethanol) up to 15 days.
RNA extraction and qPCR
RNA was extracted using TRIZOL (Invitrogen) and cDNA synthesis was performed using the Cloned AMV First-Strand cDNA Synthesis Kit (Invitrogen). Quantification of mRNA levels was carried out by real time PCR using SYBER Green. qPCR levels were normalized to GAPDH in human cells and to 18S in zebrafish.
ChIP assays
Chromatin immunoprecipitation (ChIP) assays were performed according to Adamo et al., (Adamo et al., 2011) . The antibodies used were antiH3K4me2 (07030 from Millipore), H3K4me3 (07-473 from Millipore), and H3K27me3 (07-449 from Millipore). Purified chromatin was quantified using qPCR. The sequences of the oligonucleotides are available on request.
Lentiviral production and infection
Previously described short hairpin against SMYD2 (Huang et al., 2006 ) and a non target short hairpin were cloned into the lentiviral pLVTHM vector (Addgene plasmid 12247). Virus production was performed as described (Wiznerowicz and Trono, 2003) . After infection, GFP positive cells were selected by FACS sorting.
Vector construction and transfection
Flag-tagged SMYD2 cDNA was cloned into vector pTP6 (Pratt et al., 2000) . ES[4] were transfected with linearized pTP6-SMYD2 and pTP6 empty vector and clones were selected with 2ug/ml puromycin and pooled. SMYD2 expression was confirmed by qPCR and western blot.
Zebrafish microinjection of morpholino and SMYD2 mRNA
Antisense morpholino-oligonucleotides (MO) were supplied by Gene Tools LCC (Philomath, OR). The sequence of smyd2a splice-blocking MO (smyd2a-MO) is 5' TTATAAGGAGCGCTGACCTGGTAAA 3' and was designed to block smyd2a proper splicing by binding to the splice site located between exon 1 and intron 1. The sequence of the standard control MO (Control-MO) was 5' CCTCTTACCTCAGTTACAATTTATA 3' and was dorsalization effects were consistent with reduced or absent levels of ntl transcript at 6 hpf. On the contrary, knockdown of SMYD2 in human ES cell differentiation did not affect the expression of the ntl ortholog, BRACHYURY (Fig. 3A) . This discrepancy might be caused by the differences between the two model systems or to the lower efficiency of SMYD2 knockdown in ES cells. We also observed increased expression levels of Nodal-related genes, such as bon and cas, described to promote the formation of endoderm in zebrafish (Reiter et al., 2001 , Stainier, 2002 . Also, in Xenopus, goosecoid and Mix.1, the homologous genes of gsc and bon respectively, act together to promote endodermal differentiation and suppress expression of mesodermal Xbra, the ntl homologous gene (Latinkic and Smith, 1999) . Eventually, high levels of gsc and bon at 6 and 8 hpf in smyd2a-MO embryos might have repressive effects over mesoderm induction. Overall, the zebrafish phenotype seems consistent with the induction of endodermal genes in the knockdown of SMYD2 during human ES cell differentiation.
Since, SMYD2 has been previously involved in transcriptional activation through monomethylation of H3K4 we speculate that it might participate in the induction of repressors of the endodermal fate. Alternatively, it might act as a transcriptional repressor itself through its association with HDACI 
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used as an injection control. MOs were diluted in Danieau buffer to a final concentration of 0.35 mM and were injected at 1-2 cell stage of fertilized wild-type zebrafish (AB strain) eggs using microinjector. Flag-tagged SMYD2 cDNA was cloned into pCS2 vector for mRNA synthesis using the mMESSAGE mMACHINE kit (Ambion, AMI344, Life Technologies, USA) following the manufacturer's instructions. Rescue experiments were performed by co-injecting 30 pg of synthesized SMYD2 mRNA with 0.35mM of smyd2a-MO or Control-MO.
Whole mount in situ hybridization
Antisense ntl RNA probe was synthesized using the DIG RNA Labeling Kit SP6/T7 (Roche). Embryos were collected and fixed at 6 hpf. Whole mount in situ hybridization was performed as previously described (Jopling et al., 2010) .
